Cargando…

Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020

OBJECTIVE: To describe the clinical and respiratory characteristics of a cohort of 43 patients with COVID-19 after an evolutive period of 28 days. DESIGN: A prospective, single-center observational study was carried out. Setting: Intensive care. PATIENTS: Patients admitted due to COVID-19 and respir...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, A., Moreno, G., Gómez, J., Carbonell, R., Picó-Plana, E., Benavent Bofill, C., Sánchez Parrilla, R., Trefler, S., Esteve Pitarch, E., Canadell, L., Teixido, X., Claverias, L., Bodí, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. y SEMICYUC. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303662/
https://www.ncbi.nlm.nih.gov/pubmed/32654921
http://dx.doi.org/10.1016/j.medin.2020.05.018
_version_ 1783548107344052224
author Rodríguez, A.
Moreno, G.
Gómez, J.
Carbonell, R.
Picó-Plana, E.
Benavent Bofill, C.
Sánchez Parrilla, R.
Trefler, S.
Esteve Pitarch, E.
Canadell, L.
Teixido, X.
Claverias, L.
Bodí, M.
author_facet Rodríguez, A.
Moreno, G.
Gómez, J.
Carbonell, R.
Picó-Plana, E.
Benavent Bofill, C.
Sánchez Parrilla, R.
Trefler, S.
Esteve Pitarch, E.
Canadell, L.
Teixido, X.
Claverias, L.
Bodí, M.
author_sort Rodríguez, A.
collection PubMed
description OBJECTIVE: To describe the clinical and respiratory characteristics of a cohort of 43 patients with COVID-19 after an evolutive period of 28 days. DESIGN: A prospective, single-center observational study was carried out. Setting: Intensive care. PATIENTS: Patients admitted due to COVID-19 and respiratory failure. INTERVENTIONS: None. VARIABLES: Automatic recording was made of demographic variables, severity parameters, laboratory data, assisted ventilation (HFO: high-flow oxygen therapy and IMV: invasive mechanical ventilation), oxygenation (PaO(2), PaO(2)/FiO(2)) and complications. The patients were divided into three groups: survivors (G1), deceased (G2) and patients remaining under admission (G3). The chi-squared test or Fisher exact test (categorical variables) was used, along with the Mann-Whitney U-test or Wilcoxon test for analyzing the differences between medians. Statistical significance was considered for p<0.05. RESULTS: A total of 43 patients were included (G1 = 28 [65.1%]; G2 = 10 [23.3%] and G3 = 5 [11.6%]), with a mean age of 65 years (range: 52-72), 62% males, APACHE II 18 (15-24), SOFA 6 (4-7). Arterial hypertension (30.2%) and obesity (25.6%) were the most frequent comorbidities. High-flow oxygen therapy was used in 62.7% of the patients, with failure in 85%. In turn, 95% of the patients required IMV and 85% received ventilation in prone decubitus. In the general population, initial PaO(2)/FiO(2) improved after 7 days (165 [125-210] vs.194 [153-285]; p=0.02), in the same way as in G1 (164 [125-197] vs. 207 [160-294]; p=0.07), but not in G2 (163 [95-197] vs. 135 [85-177]). No bacterial coinfection was observed. The incidence of IMV-associated pneumonia was high (13 episodes/1000 days of IMV). CONCLUSIONS: Patients with COVID-19 require early IMV, a high frequency of ventilation in prone decubitus, and have a high incidence of failed HFO. The lack of improvement of PaO(2)/FiO(2) at 7 days could be a prognostic marker. .
format Online
Article
Text
id pubmed-7303662
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier España, S.L.U. y SEMICYUC.
record_format MEDLINE/PubMed
spelling pubmed-73036622020-06-19 Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020 Rodríguez, A. Moreno, G. Gómez, J. Carbonell, R. Picó-Plana, E. Benavent Bofill, C. Sánchez Parrilla, R. Trefler, S. Esteve Pitarch, E. Canadell, L. Teixido, X. Claverias, L. Bodí, M. Med Intensiva Original OBJECTIVE: To describe the clinical and respiratory characteristics of a cohort of 43 patients with COVID-19 after an evolutive period of 28 days. DESIGN: A prospective, single-center observational study was carried out. Setting: Intensive care. PATIENTS: Patients admitted due to COVID-19 and respiratory failure. INTERVENTIONS: None. VARIABLES: Automatic recording was made of demographic variables, severity parameters, laboratory data, assisted ventilation (HFO: high-flow oxygen therapy and IMV: invasive mechanical ventilation), oxygenation (PaO(2), PaO(2)/FiO(2)) and complications. The patients were divided into three groups: survivors (G1), deceased (G2) and patients remaining under admission (G3). The chi-squared test or Fisher exact test (categorical variables) was used, along with the Mann-Whitney U-test or Wilcoxon test for analyzing the differences between medians. Statistical significance was considered for p<0.05. RESULTS: A total of 43 patients were included (G1 = 28 [65.1%]; G2 = 10 [23.3%] and G3 = 5 [11.6%]), with a mean age of 65 years (range: 52-72), 62% males, APACHE II 18 (15-24), SOFA 6 (4-7). Arterial hypertension (30.2%) and obesity (25.6%) were the most frequent comorbidities. High-flow oxygen therapy was used in 62.7% of the patients, with failure in 85%. In turn, 95% of the patients required IMV and 85% received ventilation in prone decubitus. In the general population, initial PaO(2)/FiO(2) improved after 7 days (165 [125-210] vs.194 [153-285]; p=0.02), in the same way as in G1 (164 [125-197] vs. 207 [160-294]; p=0.07), but not in G2 (163 [95-197] vs. 135 [85-177]). No bacterial coinfection was observed. The incidence of IMV-associated pneumonia was high (13 episodes/1000 days of IMV). CONCLUSIONS: Patients with COVID-19 require early IMV, a high frequency of ventilation in prone decubitus, and have a high incidence of failed HFO. The lack of improvement of PaO(2)/FiO(2) at 7 days could be a prognostic marker. . Elsevier España, S.L.U. y SEMICYUC. 2020-12 2020-06-19 /pmc/articles/PMC7303662/ /pubmed/32654921 http://dx.doi.org/10.1016/j.medin.2020.05.018 Text en © 2020 Elsevier España, S.L.U. y SEMICYUC. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original
Rodríguez, A.
Moreno, G.
Gómez, J.
Carbonell, R.
Picó-Plana, E.
Benavent Bofill, C.
Sánchez Parrilla, R.
Trefler, S.
Esteve Pitarch, E.
Canadell, L.
Teixido, X.
Claverias, L.
Bodí, M.
Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020
title Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020
title_full Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020
title_fullStr Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020
title_full_unstemmed Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020
title_short Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020
title_sort infección grave por coronavirus sars-cov-2: experiencia en un hospital de tercer nivel con pacientes afectados por covid-19 durante la pandemia 2020
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303662/
https://www.ncbi.nlm.nih.gov/pubmed/32654921
http://dx.doi.org/10.1016/j.medin.2020.05.018
work_keys_str_mv AT rodrigueza infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT morenog infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT gomezj infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT carbonellr infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT picoplanae infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT benaventbofillc infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT sanchezparrillar infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT treflers infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT estevepitarche infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT canadelll infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT teixidox infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT claveriasl infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT bodim infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020
AT infecciongraveporcoronavirussarscov2experienciaenunhospitaldetercernivelconpacientesafectadosporcovid19durantelapandemia2020